I’m glad I chose HUMATE-P. It worked really well for me.”
—Bekah, a person with VWD who uses HUMATE-P
HUMATE-P can help you manage VWD
HUMATE-P is a VWF replacement therapy
It is made from human plasma and restores the functional von Willebrand factor (VWF) activity your body is missing.
HUMATE-P provides both VWF and Factor VIII, a clotting factor that is also deficient in many people who have VWD, in a single therapy.
30+ years of treatment experience
In clinical studies, HUMATE-P provided reliable hemostatic control for all VWD types, including Type 3—the most severe form. HUMATE-P is proven effective in patients of all ages—from infants to adults—against multiple types of bleeds:
- Spontaneous bleeding episodes
- Trauma-induced bleeding episodes
- Bleeding before and after surgery
HUMATE-P provided excellent or good bleed control across multiple clinical studies of patients with VWD
of bleeds
(344 nonsurgical
bleeds in 97 patients)
of urgent surgery patients
(39 urgent surgeries
in 39 patients)
Excellent: Hemostasis clinically not significantly different from normal
Good: Mildly abnormal hemostasis in terms of quantity and/or quality (e.g., slight oozing)
For Bekah, HUMATE-P and her mother helped with the birthing experience
I’m glad I chose HUMATE-P. It worked really well for me.” —Bekah, a person with VWD who uses HUMATE-P
Individual experience may vary.
For Bekah, HUMATE-P and her mother helped with the birthing experience
HUMATE-P provides VWF that is similar to normal plasma
HUMATE-P contains the VWF proteins that are important for correcting the coagulation defect in people with VWD. Several studies have shown that the composition of these VWF proteins in HUMATE-P is similar to the VWF proteins found in normal plasma.
In some types of VWD, VWF and FVIII are needed for effective bleed control
FVIII may be missing in many people who have VWD. With insufficient FVIII activity, it can take much longer for a stable blood clot to form.
HUMATE-P provides VWF and FVIII in a 2.4 to 1 ratio.
HUMATE-P provides VWF + FVIII (Factor VIII) in a single therapy
Dedicated to plasma-product safety
At CSL Behring, we are dedicated to meeting the most stringent international standards for plasma product safety according to guidelines from worldwide regulatory agencies. Our Integrated Safety System helps HUMATE-P meet high quality and safety standards, thus reducing the risk of virus transmissions. The risk of virus transmission cannot be completely eliminated.
